Michael Findlay
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 35
- Cancer Treatment and Pharmacology 12
- Pancreatic and Hepatic Oncology Research 8
- Colorectal Cancer Screening and Detection 8
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 17
- Gastroenterology top 2%
-
- Gastric Cancer Management and Outcomes 11
- Family Practice top 5%
-
- Genetic factors in colorectal cancer 10
-
- Colorectal and Anal Carcinomas 9
- Co-authors
- David CunninghamPierce K. H. ChowAnna K. NowakMichael J. SolomonTamas HickishJim CassidyB OsterwalderChris Twelves
- Cited by
- OncologyHepatologyGastroenterology
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (11 papers)Cancer Chemotherapy and Pharmacology (5 papers)
- Partner nations
- New ZealandAustraliaUnited Kingdom
In The Last Decade
Michael Findlay
107 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 141
- Oncology 1.6k
- Hepatology 347
- Gastroenterology 239
- Pulmonary and Respiratory Medicine 988
- Family Practice 62
Countries citing papers authored by Michael Findlay
This map shows the geographic impact of Michael Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Findlay more than expected).
Fields of papers citing papers by Michael Findlay
This network shows the impact of papers produced by Michael Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Findlay. The network helps show where Michael Findlay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Findlay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Gene expression profiling of breast tumours from New Zealand patients. | 2017 | 2 |
| 3 | Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care. | 2017 | 4 |
| 4 | 2017 | 1 | |
| 5 | 2017 | 7 | |
| 6 | 2016 | 4 | |
| 7 | 2015 | 0 | |
| 8 | 2015 | 23 | |
| 9 | 2013 | 5 | |
| 10 | Dietary patterns and information needs of colorectal cancer patients post-surgery in Auckland. | 2012 | 9 |
| 11 | 2011 | 4 | |
| 12 | 2011 | 33 | |
| 13 | 2010 | 42 | |
| 14 | 2010 | 7 | |
| 15 | 2010 | 51 | |
| 16 | 2003 | 70 | |
| 17 | Phenytoin toxicity as a result of 5-fluorouracil administration. | 2002 | 7 |
| 18 | 2000 | 26 | |
| 19 | 1997 | 86 | |
| 20 | 1996 | 220 |
About Michael Findlay
Michael Findlay is a scholar working on Oncology, Hepatology and Gastroenterology, having authored 111 papers that have together received 3.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Cancer Treatment and Pharmacology (12 papers), Gastric Cancer Management and Outcomes (11 papers), Genetic factors in colorectal cancer (10 papers), Colorectal and Anal Carcinomas (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Colorectal Cancer Screening and Detection (8 papers). The work is most often cited by research in Oncology (1.6k citations), Hepatology (347 citations) and Gastroenterology (239 citations). Michael Findlay has collaborated with scholars based in New Zealand, Australia and United Kingdom. Frequent co-authors include David Cunningham, Pierce K. H. Chow, Anna K. Nowak, Michael J. Solomon, Tamas Hickish, Jim Cassidy, B Osterwalder, Chris Twelves, Andrew Wardley and Gϋnter von Minckwitz. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, European Journal of Cancer and ANZ Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.